M.F. Aillaud

Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis

I. Juhan‐Vague, J Valadier, Marie‐Christine Alessi et al. · Thrombosis and Haemostasis · 1987 · 367 citations

Medicine, Pharmacology, Surgery +16

Clearance of Tissue Plasminogen Activator (TPA) and TPA/Plasminogen Activator Inhibitor Type 1 (PAI-1) Complex

Wayne L. Chandler, Marie‐Christine Alessi, M.F. Aillaud et al. · Circulation · 1997 · 245 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions

I. Juhan‐Vague, B. Moerman, F De Cock et al. · Thrombosis Research · 1984 · 241 citations

Life Sciences, Pathobiology, Pharmacodynamics +7

Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe

I. Juhan‐Vague, Pierre‐Emmanuel Morange, H. Aubert et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 147 citations · Full text

Medicine, Cardiology, Genetics +13

Metabolic Determinants Are Much More Important Than Genetic Polymorphisms in Determining the PAI-1 Activity and Antigen Plasma Concentrations

M. Henry, David‐Alexandre Trégouët, Marie‐Christine Alessi et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1998 · 124 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17